Safety of rituximab in rheumatoid arthritis: Results of a pooled analysis

被引:0
|
作者
van Vollenhoven, R. F.
Emery, P.
Bingham, C.
Keystone, E.
Greenwalds, M.
Moreland, L. W.
Kim, D.
Cooper, S.
Wagner, B.
Ward, P.
机构
[1] Karolinska Univ Hosp, Dept Rheumatol, Stockholm, Sweden
[2] Leeds Gen Infirm, Dept Rheumatol, Leeds, W Yorkshire, England
[3] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD 21218 USA
[4] Univ Toronto, Dept Rheumatol, Toronto, ON, Canada
[5] Desert Med Adv, Palm Desert, CA USA
[6] Univ Alabama, Sch Med, Dept Rheumatol, Tuscaloosa, AL 35487 USA
[7] Biogen Idec, San Diego, CA USA
[8] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[9] Genentech Inc, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:332 / 332
页数:1
相关论文
共 50 条
  • [41] Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
    van Vollenhoven, Ronald F.
    Emery, Paul
    Bingham, Clifton O., III
    Keystone, Edward C.
    Fleischmann, Roy
    Furst, Daniel E.
    Macey, Katherine
    Sweetser, Marianne
    Kelman, Ariella
    Rao, Ravi
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (03) : 558 - 567
  • [42] Safety of Rapid Rituximab Infusion in Rheumatoid Arthritis in a Single Community Practice
    Faraawi, Rafat
    Roth, Kelly
    Malik, Sameeka
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1329 - 1330
  • [43] Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
    John D Hainsworth
    Arthritis Res Ther, 5
  • [44] Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis
    Bonnet, Isabelle
    Rousseau, Antoine
    Duraffour, Pierre
    Pouchot, Jacques
    Nguyen, Chi Duc
    Gabison, Eric
    Seror, Raphaele
    Marotte, Hubert
    Mariette, Xavier
    Nocturne, Gaetane
    RMD OPEN, 2021, 7 (01):
  • [45] Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
    Richa Mishra
    Vijay Singh
    Charles H. Pritchard
    Rheumatology International, 2011, 31 : 481 - 484
  • [46] Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab
    Breedveld, F. C.
    Khraishi, M. M.
    Genovese, M.
    Emery, P.
    Moreland, L. W.
    Keystone, E.
    Matteson, E. L.
    Burke, L.
    Agarwal, S.
    Kim, D.
    Cooper, S.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1602 - 1602
  • [47] Safety of Rapid Rituximab Infusion in Rheumatoid Arthritis in a Single Community Practice
    Faraawi, Rafat
    Roth, Kelly
    Malik, Sameeka
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1034 - S1034
  • [48] Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
    Hainsworth, JD
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 4) : S12 - S16
  • [49] Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients
    Genovese, M. C.
    Breedveld, F. C.
    Emery, P.
    Cohen, S.
    Keystone, E.
    Matteson, E. L.
    Baptiste, Y.
    Chai, A.
    Burke, L.
    Reiss, W.
    Sweetser, M.
    Shaw, T. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (12) : 1894 - 1897
  • [50] Safety of TNF inhibitors in rheumatoid arthritis patients previously treated with rituximab
    Breedveld, F. C.
    Genovese, M.
    Emery, P.
    Moreland, L. W.
    Keystone, E.
    Matteson, E. L.
    Burke, L.
    Agarwal, S.
    Kim, D.
    Cooper, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 178 - 179